Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3501682016 | Paracetamol 500 mg and phenyltoloxamine citrate 50 mg oral tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3501683014 | Acetaminophen 500 mg and phenyltoloxamine citrate 50 mg oral tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3681713010 | Product containing precisely paracetamol 500 milligram and phenyltoloxamine citrate 50 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Paracetamol 500 mg and phenyltoloxamine citrate 50 mg oral tablet | Is a | Product containing phenyltoloxamine (medicinal product) | false | Inferred relationship | Some | ||
Paracetamol 500 mg and phenyltoloxamine citrate 50 mg oral tablet | Has active ingredient | Ethanolamine | false | Inferred relationship | Some | ||
Paracetamol 500 mg and phenyltoloxamine citrate 50 mg oral tablet | Has active ingredient | Sedating antihistamine | false | Inferred relationship | Some | ||
Paracetamol 500 mg and phenyltoloxamine citrate 50 mg oral tablet | Has active ingredient | Phenyltoloxamine (substance) | false | Inferred relationship | Some | ||
Paracetamol 500 mg and phenyltoloxamine citrate 50 mg oral tablet | Is a | Product containing paracetamol and phenyltoloxamine citrate | false | Inferred relationship | Some | ||
Paracetamol 500 mg and phenyltoloxamine citrate 50 mg oral tablet | Has active ingredient | Paracetamol | false | Inferred relationship | Some | ||
Paracetamol 500 mg and phenyltoloxamine citrate 50 mg oral tablet | Has active ingredient | Non-opioid analgesic (substance) | false | Inferred relationship | Some | ||
Paracetamol 500 mg and phenyltoloxamine citrate 50 mg oral tablet | Has active ingredient | Phenyltoloxamine citrate | false | Inferred relationship | Some | ||
Paracetamol 500 mg and phenyltoloxamine citrate 50 mg oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Some | ||
Paracetamol 500 mg and phenyltoloxamine citrate 50 mg oral tablet | Has active ingredient | Cardiovascular agent (substance) | false | Inferred relationship | Some | ||
Paracetamol 500 mg and phenyltoloxamine citrate 50 mg oral tablet | Has manufactured dose form | Oral tablet | true | Inferred relationship | Some | ||
Paracetamol 500 mg and phenyltoloxamine citrate 50 mg oral tablet | Is a | Product containing paracetamol in oral dose form (medicinal product form) | false | Inferred relationship | Some | ||
Paracetamol 500 mg and phenyltoloxamine citrate 50 mg oral tablet | Has active ingredient | Phenyltoloxamine citrate | false | Inferred relationship | Some | 1 | |
Paracetamol 500 mg and phenyltoloxamine citrate 50 mg oral tablet | Has basis of strength substance (attribute) | Phenyltoloxamine citrate | true | Inferred relationship | Some | 1 | |
Paracetamol 500 mg and phenyltoloxamine citrate 50 mg oral tablet | Has presentation strength numerator value | 50 | false | Inferred relationship | Some | 1 | |
Paracetamol 500 mg and phenyltoloxamine citrate 50 mg oral tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
Paracetamol 500 mg and phenyltoloxamine citrate 50 mg oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 1 | |
Paracetamol 500 mg and phenyltoloxamine citrate 50 mg oral tablet | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 1 | |
Paracetamol 500 mg and phenyltoloxamine citrate 50 mg oral tablet | Has active ingredient | Paracetamol | false | Inferred relationship | Some | 2 | |
Paracetamol 500 mg and phenyltoloxamine citrate 50 mg oral tablet | Has basis of strength substance (attribute) | Paracetamol | true | Inferred relationship | Some | 2 | |
Paracetamol 500 mg and phenyltoloxamine citrate 50 mg oral tablet | Has presentation strength numerator value | 500 | false | Inferred relationship | Some | 2 | |
Paracetamol 500 mg and phenyltoloxamine citrate 50 mg oral tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 2 | |
Paracetamol 500 mg and phenyltoloxamine citrate 50 mg oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 2 | |
Paracetamol 500 mg and phenyltoloxamine citrate 50 mg oral tablet | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 2 | |
Paracetamol 500 mg and phenyltoloxamine citrate 50 mg oral tablet | Has precise active ingredient | Phenyltoloxamine citrate | true | Inferred relationship | Some | 1 | |
Paracetamol 500 mg and phenyltoloxamine citrate 50 mg oral tablet | Has precise active ingredient | Paracetamol | true | Inferred relationship | Some | 2 | |
Paracetamol 500 mg and phenyltoloxamine citrate 50 mg oral tablet | Has unit of presentation | Tablet (unit of presentation) | true | Inferred relationship | Some | ||
Paracetamol 500 mg and phenyltoloxamine citrate 50 mg oral tablet | Is a | Product containing paracetamol and phenyltoloxamine in oral dose form (medicinal product form) | false | Inferred relationship | Some | ||
Paracetamol 500 mg and phenyltoloxamine citrate 50 mg oral tablet | Count of base of active ingredient | 2 | false | Inferred relationship | Some | ||
Paracetamol 500 mg and phenyltoloxamine citrate 50 mg oral tablet | Is a | Product containing only paracetamol and phenyltoloxamine in oral dose form (medicinal product form) | true | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets